Desi Pan

1.3k total citations · 1 hit paper
23 papers, 882 citations indexed

About

Desi Pan is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Desi Pan has authored 23 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Desi Pan's work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Desi Pan is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Desi Pan collaborates with scholars based in China, United States and Hong Kong. Desi Pan's co-authors include Xianping Lu, Lucia Schuger, Zhiqiang Ning, Xiaoning Zhe, Song Shan, Zhibin Li, Xinhao Wang, Xin Du, Mei Dong and Michael Newman and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Cell Biology and Scientific Reports.

In The Last Decade

Desi Pan

23 papers receiving 860 citations

Hit Papers

Advances in targeting histone deacetylase for treatment o... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Advances in targeting histone deacetylase for treatment of solid tumors
    2024 56 citations Ying Xu, Xin Fu et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Desi Pan China 14 614 248 86 82 78 23 882
Lili Shu United States 8 685 1.1× 193 0.8× 86 1.0× 62 0.8× 121 1.6× 12 880
Charlotte E. Edling United Kingdom 14 606 1.0× 273 1.1× 48 0.6× 136 1.7× 63 0.8× 32 1.0k
Yuan Xiao Zhu United States 14 855 1.4× 250 1.0× 67 0.8× 134 1.6× 45 0.6× 26 1.1k
Chang-Goo Huh United States 9 508 0.8× 184 0.7× 85 1.0× 119 1.5× 71 0.9× 10 1.2k
Stephan Lindsey United States 14 421 0.7× 163 0.7× 38 0.4× 126 1.5× 43 0.6× 18 726
Jacob G. Kirkland United States 15 792 1.3× 243 1.0× 160 1.9× 75 0.9× 91 1.2× 21 1.2k
Tzu‐Hao Wang Taiwan 13 502 0.8× 145 0.6× 41 0.5× 58 0.7× 61 0.8× 16 861
Rafael B. Blasco Spain 15 534 0.9× 173 0.7× 161 1.9× 208 2.5× 89 1.1× 29 1.1k
Sonali P. Barwe United States 20 714 1.2× 206 0.8× 31 0.4× 119 1.5× 111 1.4× 66 1.1k
Manjiri M. Bakre India 14 515 0.8× 199 0.8× 55 0.6× 77 0.9× 71 0.9× 32 822

Countries citing papers authored by Desi Pan

Since Specialization
Citations

This map shows the geographic impact of Desi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desi Pan more than expected).

Fields of papers citing papers by Desi Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desi Pan. The network helps show where Desi Pan may publish in the future.

Co-authorship network of co-authors of Desi Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Desi Pan. A scholar is included among the top collaborators of Desi Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desi Pan. Desi Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Ying, Xin Fu, Desi Pan, et al.. (2024). Advances in targeting histone deacetylase for treatment of solid tumors. Journal of Hematology & Oncology. 17(1). 37–37. 56 indexed citations breakdown →
3.
Li, Dan, et al.. (2024). CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models. Immunopharmacology and Immunotoxicology. 46(4). 529–537. 1 indexed citations
4.
5.
Wang, Wei, Yiru Zhao, Hua Zhong, et al.. (2023). CS27109, A Selective Thyroid Hormone Receptor-β Agonist Alleviates Metabolic-Associated Fatty Liver Disease in Murine Models. International Journal of Endocrinology. 2023. 1–11. 8 indexed citations
6.
Sun, Yi-Chen, Jing Han Hong, Zhiqiang Ning, et al.. (2022). Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment. Frontiers in Pharmacology. 13. 932914–932914. 47 indexed citations
7.
8.
Pan, Desi & Xianping Lu. (2020). New therapeutic avenue of epigenetic modulations in cancer. 1. 2–2. 2 indexed citations
9.
Zhou, You, Chao Fu, Yidi Kong, et al.. (2019). Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models. Anti-Cancer Drugs. 30(9). 909–916. 11 indexed citations
10.
Shan, Song, You Zhou, Desi Pan, et al.. (2019). Therapeutic treatment of a novel selective JAK3/JAK1/TBK1 inhibitor, CS12192, in rat and mouse models of rheumatoid arthritis. International Immunopharmacology. 77. 105914–105914. 14 indexed citations
11.
Pan, Desi, Wei Wang, Kun Zhang, et al.. (2017). Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPARγ. PPAR Research. 2017. 1–16. 32 indexed citations
12.
Zhou, You, Song Shan, Zhibin Li, et al.. (2016). CS2164, a novel multi‐target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti‐tumor potency. Cancer Science. 108(3). 469–477. 37 indexed citations
13.
Zhou, You, Desi Pan, Song Shan, et al.. (2014). Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells. Biomedicine & Pharmacotherapy. 68(4). 483–491. 57 indexed citations
14.
He, Bing, Zhengwen Ning, Shan Song, et al.. (2012). In VitroandIn VivoCharacterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist. PPAR Research. 2012. 1–13. 41 indexed citations
15.
Ning, Zhiqiang, Zhibin Li, Michael Newman, et al.. (2011). Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity. Cancer Chemotherapy and Pharmacology. 69(4). 901–909. 221 indexed citations
16.
Wong, Jason, Lei Guo, Zhenghong Peng, et al.. (2010). Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry Letters. 21(1). 110–116. 10 indexed citations
17.
Zhe, Xiaoning, et al.. (2005). TIPs Are Tension-Responsive Proteins Involved in Myogenic versus Adipogenic Differentiation. Developmental Cell. 9(1). 39–49. 58 indexed citations
18.
Li, Zhibin, Chenzhong Liao, Ben C.B. Ko, et al.. (2004). Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARα selective activators. Bioorganic & Medicinal Chemistry Letters. 14(13). 3507–3511. 16 indexed citations
19.
Pan, Desi, et al.. (2002). P311 induces a TGF-β1–independent, nonfibrogenic myofibroblast phenotype. Journal of Clinical Investigation. 110(9). 1349–1358. 2 indexed citations
20.
Pan, Desi, et al.. (2002). P311 induces a TGF-β1–independent, nonfibrogenic myofibroblast phenotype. Journal of Clinical Investigation. 110(9). 1349–1358. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lili Shu Breakdown of academic impact, for papers by Charlotte E. Edling Breakdown of academic impact, for papers by Yuan Xiao Zhu Breakdown of academic impact, for papers by Chang-Goo Huh Breakdown of academic impact, for papers by Stephan Lindsey Breakdown of academic impact, for papers by Jacob G. Kirkland Breakdown of academic impact, for papers by Tzu‐Hao Wang Breakdown of academic impact, for papers by Rafael B. Blasco Breakdown of academic impact, for papers by Sonali P. Barwe Breakdown of academic impact, for papers by Manjiri M. Bakre
Rankless by CCL
2026